Pharmaceuticals India,Pharmaceuticals Company,Indian Pharmaceuticals Company,Pharmaceuticals Exporters India,Pharmaceutical Exporter

Medicamen Biotech Limited is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services services to the medical Fraternity since 1993.

Board of Directors

Manufacturing Facilities

Approvals/Registrations

Awards

10^thAnnual Day

Careers

Home | About Us | Contact | Enquiry | Mail Us

Welcome to MEDICAMEN BIOTECH LIMITED

Medicamen Biotech Limited is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price thereby being socially responsible and rendering services to the Medical Fraternity since 1993.

read more...


Awards	Visit to our Manufacturing Facilities

MD's Vision His Vision
Medicamen Biotech Limited , is widely accepted company in several countries including Africa & Latin American Countries. Very recently Medicamen Biotech Limited has been accredited as approved supplier for PAHO (Pan American Health Organizations). The Company has embarked upon an aggressive programme of exporting it's products to several countries from which there are enormous demand and enquiries for it's formulations. Over the next few years there is expected to be an impressive spurt in revenue from export business.
Medicamen Biotech Limited has finalized tie ups with highly reputed pharmaceutical importers and distributors in Africa, Central America, CIS and the South East Asia to market its products. Medicamen Biotech Limited has a well equipped Regulatory Affairs Department to provide the registration requirements for the Ministries of Health, FDA & Regulatory Authorities of Various Countries.
Medicamen Biotech Limited having an annual growth of 20 to 24% and is planning to export at least US$ 25 million worth of goods over the next 3 years.
Medicamen Biotech Limited has planning to intensify its activities in the product segment of Anti- Retroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.
Beside these product lines, the company will explore new molecules & formulations so as to meet demand of Medical Fraternity.

Medicamen Biotech Limited , is widely accepted company in several countries including Africa & Latin American Countries. Very recently Medicamen Biotech Limited has been accredited as approved supplier for PAHO (Pan American Health Organizations). The Company has embarked upon an aggressive programme of exporting it's products to several countries from which there are enormous demand and enquiries for it's formulations. Over the next few years there is expected to be an impressive spurt in revenue from export business.
Medicamen Biotech Limited , has finalized tie ups with highly reputed pharmaceutical importers and distributors in Africa, Central America, CIS and the South East Asia to market its products. Medicamen Biotech Limited has a well equipped Regulatory Affairs Department to provide the registration requirements for the Ministries of Health, FDA & Regulatory Authorities of Various Countries.
Medicamen Biotech Limited having an annual growth of 20 to 24% and is planning to export at least US$ 25 million worth of goods over the next 3 years.
Medicamen Biotech Limited has planning to intensify its activities in the product segment of Anti- Retroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.
Beside these product lines, the company will explore new molecules & formulations so as to meet demand of Medical Fraternity.Medicamen Biotech Limited , is widely accepted company in several countries including Africa & Latin American Countries. Very recently Medicamen Biotech Limited has been accredited as approved supplier for PAHO (Pan American Health Organizations). The Company has embarked upon an aggressive programme of exporting it's products to several countries from which there are enormous demand and enquiries for it's formulations. Over the next few years there is expected to be an impressive spurt in revenue from export business.
Medicamen Biotech Limited , has finalized tie ups with highly reputed pharmaceutical importers and distributors in Africa, Central America, CIS and the South East Asia to market its products. Medicamen Biotech Limited has a well equipped Regulatory Affairs Department to provide the registration requirements for the Ministries of Health, FDA & Regulatory Authorities of Various Countries.
Medicamen Biotech Limited having an annual growth of 20 to 24% and is planning to export at least US$ 25 million worth of goods over the next 3 years.
Medicamen Biotech Limited has planning to intensify its activities in the product segment of Anti- Retroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.
Beside these product lines, the company will explore new molecules & formulations so as to meet demand of Medical Fraternity.Medicamen Biotech Limited , is widely accepted company in several countries including Africa & Latin American Countries. Very recently Medicamen Biotech Limited has been accredited as approved supplier for PAHO (Pan American Health Organizations). The Company has embarked upon an aggressive programme of exporting it's products to several countries from which there are enormous demand and enquiries for it's formulations. Over the next few years there is expected to be an impressive spurt in revenue from export business.
Medicamen Biotech Limited , has finalized tie ups with highly reputed pharmaceutical importers and distributors in Africa, Central America, CIS and the South East Asia to market its products. Medicamen Biotech Limited has a well equipped Regulatory Affairs Department to provide the registration requirements for the Ministries of Health, FDA & Regulatory Authorities of Various Countries.
Medicamen Biotech Limited having an annual growth of 20 to 24% and is planning to export at least US$ 25 million worth of goods over the next 3 years.
Medicamen Biotech Limited has planning to intensify its activities in the product segment of Anti- Retroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.
Beside these product lines, the company will explore new molecules & formulations so as to meet demand of Medical Fraternity.Medicamen Biotech Limited , is widely accepted company in several countries including Africa & Latin American Countries. Very recently Medicamen Biotech Limited has been accredited as approved supplier for PAHO (Pan American Health Organizations). The Company has embarked upon an aggressive programme of exporting it's products to several countries from which there are enormous demand and enquiries for it's formulations. Over the next few years there is expected to be an impressive spurt in revenue from export business.
Medicamen Biotech Limited , has finalized tie ups with highly reputed pharmaceutical importers and distributors in Africa, Central America, CIS and the South East Asia to market its products. Medicamen Biotech Limited has a well equipped Regulatory Affairs Department to provide the registration requirements for the Ministries of Health, FDA & Regulatory Authorities of Various Countries.
Medicamen Biotech Limited having an annual growth of 20 to 24% and is planning to export at least US$ 25 million worth of goods over the next 3 years.
Medicamen Biotech Limited has planning to intensify its activities in the product segment of Anti- Retroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.
Beside these product lines, the company will explore new molecules & formulations so as to meet demand of Medical Fraternity.Medicamen Biotech Limited , is widely accepted company in several countries including Africa & Latin American Countries. Very recently Medicamen Biotech Limited has been accredited as approved supplier for PAHO (Pan American Health Organizations). The Company has embarked upon an aggressive programme of exporting it's products to several countries from which there are enormous demand and enquiries for it's formulations. Over the next few years there is expected to be an impressive spurt in revenue from export business.
Medicamen Biotech Limited , has finalized tie ups with highly reputed pharmaceutical importers and distributors in Africa, Central America, CIS and the South East Asia to market its products. Medicamen Biotech Limited has a well equipped Regulatory Affairs Department to provide the registration requirements for the Ministries of Health, FDA & Regulatory Authorities of Various Countries.
Medicamen Biotech Limited having an annual growth of 20 to 24% and is planning to export at least US$ 25 million worth of goods over the next 3 years.
Medicamen Biotech Limited has planning to intensify its activities in the product segment of Anti- Retroviral, Anti-Malarial, Antibiotics and Anti TB Drugs.
Beside these product lines, the company will explore new molecules & formulations so as to meet demand of Medical Fraternity.

Awards

Visit to our Manufacturing Facilities